Immune regulatory abnormalities produced by procainamide
- 1 October 1982
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 73 (4) , 487-492
- https://doi.org/10.1016/0002-9343(82)90326-6
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- HLA-DR Antigens and Toxic Reaction to Sodium Aurothiomalate and D-Penicillamine in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 1980
- Methyldopa Inhibition of Suppressor-Lymphocyte FunctionNew England Journal of Medicine, 1980
- Suppressor cell activity in primary biliary cirrhosisDigestive Diseases and Sciences, 1980
- Familial Abnormalities of Suppressor-Cell Function in Systemic Lupus ErythematosusNew England Journal of Medicine, 1979
- B-Lymphocyte Alloantigens Associated with Systemic Lupus ErythematosusNew England Journal of Medicine, 1978
- Experimental studies on the mechanism of induction of anti-nuclear antibodies by procainamideClinical Immunology and Immunopathology, 1977
- Suppressor T-cell abnormality in idiopathic systemic lupus erythematosusClinical Immunology and Immunopathology, 1976
- Procainamide-induced antibodies to nucleoprotein, denatured and native DNA in human subjectsClinical Immunology and Immunopathology, 1975
- INHIBITORY AND STIMULATORY EFFECTS OF CONCANAVALIN A ON THE RESPONSE OF MOUSE SPLEEN CELL SUSPENSIONS TO ANTIGENThe Journal of Experimental Medicine, 1972
- Procainamide‐induced serologic changes in asymptomatic patientsArthritis & Rheumatism, 1969